Enterprise Value

3.246B

Cash

375.4M

Avg Qtr Burn

-8.578M

Short % of Float

6.57%

Insider Ownership

0.49%

Institutional Own.

99.19%

Qtr Updated

06/30/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date

Approved

Quarterly sales

Approved

Quarterly sales

sNDA

FDA meeting

Phase 3

Data readout

Phase 3

Data readout

ACP-204 Details
Alzheimer's disease

Phase 2/3

Data readout

ACP-044 Details
Pain, Post operative acute pain

Failed

Discontinued